She will be seeing patients starting 12/1/21!
Dr. Latta will be seeing patients starting 12/1/21!
She will be seeing patients starting 10/18/21!
Welcome to Dr. Rebecka Bogue Docken to Haugen OB/GYN! Read below to learn more about her:
I was initially drawn to the specialty of Obstetrics and Gynecology because of the diversity of this field, it combines continuity of care, preventative care, and surgical expertise. I have found that the ability to care for multiple generations and to share in their intimate moments with my patients and their families is humbling. I enjoy the long-lasting relationships that are built with patients, from their first gynecological visit, during their pregnancy and then caring for them during menopause. My special interests include contraception, endometriosis, pregnancy care, and minimally invasive gynecologic surgery.
I completed medical school in my home state of South Dakota and residency near Chicago, IL. During medical school I developed an international elective in Ghana, Africa and traveled there to bring medical care to underserved women. That experience solidified my desire to continue to advocate for women’s health and I am honored to serve this year as our districts ACOG Vice Chair.
My husband and I purchased our first home in Minneapolis and are excited to explore the many running and biking trails along the lakes. We moved my grand-mothers piano from South Dakota and I’m excited to get back to playing music. Our 7- year- old husky is overjoyed to finally have her very own backyard and she has been chasing rabbits since we arrived. We look forward to making Minneapolis our home.
Residency – Loyola University Medical Center 2020
Doctor of Medicine – Sanford School of Medicine University of South Dakota 2016
Bachelor of Arts – Augustana College, Biology, summa cum laude, 2012
District VI American College of Obstetricians and Gynecologists Vice Chair 2020 – 2021
At Haugen OB/GYN the health and safety of our patients and staff is always our number one priority. With this in mind, we are continuing to closely monitor the COVID-19 (novel coronavirus) outbreak. In addition to staying in constant contact with the Minnesota Department of Health, we are staying up-to-date with the latest information from the Centers for Disease Control (CDC) and World Health Organization (WHO).
In an effort to keep everyone safe, we are asking patients experiencing flu-like symptoms to call and reschedule their appointments. If you have traveled outside the country or on a cruise in the past 14 days, we request that you call and reschedule for a later time.
We will continue taking extra precautions to provide the safest environment possible for our patients and staff. For any questions about your appointment or your care, please call our clinic.
Call Center: 952-927-6561
At this time, very little is known about COVID-19, particularly related to its effect on pregnant women and infants, and there currently are no recommendations specific to pregnant women regarding the evaluation or management of COVID-19.
The steps to protect yourself from COVID-19 are generally the same as those for the flu:
- Wash your hands frequently with soap and water for at least 20 seconds, or with an alcohol-based hand sanitizer if soap and water are not available.
- Avoid close contact with sick people.
- Cover your cough or sneeze with a tissue or your elbow.
- Clean and disinfect frequently touched objects and surfaces using a household cleaning spray or wipe.
For information on prevention, symptoms and what to do if you’re feeling sick, please call the Minnesota Department of Health COVID-19 Hotline at 651-201-3920.
The Centers for Disease Control and Prevention has put out the following FAQ for pregnant women, those with infants, breastfeeding mothers.
Frequently Asked Questions and Answers: Coronavirus Disease 2019 (COVID-19) and Pregnancy
Q: Are pregnant women more susceptible to infection, or at increased risk for severe illness, morbidity, or mortality with COVID-19, compared with the general public?
A: We do not have information from published scientific reports about susceptibility of pregnant women to COVID-19. Pregnant women experience immunologic and physiologic changes which might make them more susceptible to viral respiratory infections, including COVID-19. Pregnant women also might be at risk for severe illness, morbidity, or mortality compared to the general population as observed in cases of other related coronavirus infections [including severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV)] and other viral respiratory infections, such as influenza, during pregnancy.
Pregnant women should engage in usual preventive actions to avoid infection like washing hands often and avoiding people who are sick.
Q: Are pregnant women with COVID-19 at increased risk for adverse pregnancy outcomes?
A: We do not have information on adverse pregnancy outcomes in pregnant women with COVID-19. Pregnancy loss, including miscarriage and stillbirth, has been observed in cases of infection with other related coronaviruses [SARS-CoV and MERS-CoV] during pregnancy. High fevers during the first trimester of pregnancy can increase the risk of certain birth defects.
Q: Are pregnant healthcare personnel at increased risk for adverse outcomes if they care for patients with COVID-19?
A: Pregnant healthcare personnel (HCP) should follow risk assessment and infection control guidelines for HCP exposed to patients with suspected or confirmed COVID-19. Adherence to recommended infection prevention and control practices is an important part of protecting all HCP in healthcare settings. Information on COVID-19 in pregnancy is very limited; facilities may want to consider limiting exposure of pregnant HCP to patients with confirmed or suspected COVID-19, especially during higher risk procedures (e.g., aerosol-generating procedures) if feasible based on staffing availability.
Transmission during pregnancy or during delivery
Q: Can pregnant women with COVID-19 pass the virus to their fetus or newborn (i.e. vertical transmission)?
A: The virus that causes COVID-19 is thought to spread mainly by close contact with an infected person through respiratory droplets. Whether a pregnant woman with COVID-19 can transmit the virus that causes COVID-19 to her fetus or neonate by other routes of vertical transmission (before, during, or after delivery) is still unknown. However, in limited recent case series of infants born to mothers with COVID-19 published in the peer-reviewed literature, none of the infants have tested positive for the virus that causes COVID-19. Additionally, virus was not detected in samples of amniotic fluid or breastmilk.
Limited information is available about vertical transmission for other coronaviruses (MERS-CoV and SARS-CoV) but vertical transmission has not been reported for these infections.
Q: Are infants born to mothers with COVID-19 during pregnancy at increased risk for adverse outcomes?
A: Based on limited case reports, adverse infant outcomes (e.g., preterm birth) have been reported among infants born to mothers positive for COVID-19 during pregnancy. However, it is not clear that these outcomes were related to maternal infection, and at this time the risk of adverse infant outcomes is not known. Given the limited data available related to COVID-19 during pregnancy, knowledge of adverse outcomes from other respiratory viral infections may provide some information. For example, other respiratory viral infections during pregnancy, such as influenza, have been associated with adverse neonatal outcomes, including low birth weight and preterm birth. Additionally, having a cold or influenza with high fever early in pregnancy may increase the risk of certain birth defects. Infants have been born preterm and/or small for gestational age to mothers with other coronavirus infections, SARS-CoV and MERS-CoV, during pregnancy.
Q: Is there a risk that COVID-19 in a pregnant woman or neonate could have long-term effects on infant health and development that may require clinical support beyond infancy?
A: At this time, there is no information on long-term health effects on infants either with COVID-19, or those exposed to the virus that causes COVID-19 in utero. In general, prematurity and low birth weight are associated with adverse long-term health effects.
Transmission through breast milk
Q: Is maternal illness with COVID-19 during lactation associated with potential risk to a breastfeeding infant?
A: Human-to-human transmission by close contact with a person with confirmed COVID-19 has been reported and is thought to occur mainly via respiratory droplets produced when a person with infection coughs or sneezes.
In limited case series reported to date, no evidence of virus has been found in the breast milk of women with COVID-19. No information is available on the transmission of the virus that causes COVID-19 through breast milk (i.e., whether infectious virus is present in the breast milk of an infected woman).
In limited reports of lactating women infected with SARS-CoV, virus has not been detected in breast milk; however, antibodies against SARS-CoV were detected in at least one sample.